Search All UT System Experts

Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: Implications for perioperative anti-FGFR3 treatment

D. Pouessel, Y. Neuzillet, L. S. Mertens, M. S. van der Heijden, J. de Jong, J. Sanders, D. Peters, K. Leroy, A. Manceau, P. Maille, P. Soyeux, A. Moktefi, F. Semprez, D. Vordos, A. de la Taille, C. D. Hurst, D. C. Tomlinson, P. Harnden, P. J. Bostrom, T. MirttiS. Horenblas, Y. Loriot, N. Houédé, C. Chevreau, P. Beuzeboc, S. F. Shariat, Arthur I Sagalowsky, R. Ashfaq, M. Burger, M. A S Jewett, A. R. Zlotta, A. Broeks, B. Bapat, M. A. Knowles, Yair Lotan, T. H. van der Kwast, S. Culine, Y. Allory, B. W G Van Rhijn

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: Implications for perioperative anti-FGFR3 treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences